Irving Investors Co-Investors 2026

Who Irving Investors invests alongside: Andreessen Horowitz, Axevil Capital, GIC — mapped across 13 portfolio companies in 5 sectors and 8 cities.

Irving Investors accounts for 5 tracked companies with verified cap-table data, 5 of which disclose round sizes totalling $972M. The median disclosed raise is $160M, and the largest is Metagenomi at $300M, ahead of Crossover Health ($292M) and Goldfinch Biopharma ($160M).

The names that recur most often on these co-invested cap tables are Irving Investors (5 companies), Farallon Capital Management (3 companies), PFM Health Sciences (2 companies), Eventide Asset Management (2 companies), Deep Track Capital (2 companies), Pura Vida Investments (2 companies). By latest disclosed round, the market skews Series B (2), Series D (2).

Best funded Irving Investors companies

  1. Metagenomi — $300M (latest: Series B)
  2. Crossover Health — $292M (latest: Series D)
  3. Goldfinch Biopharma — $160M (latest: Series B)
  4. BioTheryX — $127M
  5. LUMICKS — $93M (latest: Series D)

Irving Investors — related firms and companies (49)

Irving Investors alternatives · All research reports